Nebulizer Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

With the rapid rise in the global geriatric population, there is an increasing demand for devices and equipment that address the various health issues faced by older adults. This surge is complemented by the growing per capita income of consumers in both developed and developing regions, leading to the widespread adoption of advanced medical devices for treating a range of diseases. As a result, manufacturers of nebulizer devices are witnessing a shift in pricing strategies as production moves to emerging economies.

Shift in Production Dynamics

The shift in the production of nebulizer devices to developing regions is largely due to the availability of affordable land. Major companies like Koninklijke Philips N.V., Becton, Dickinson and Company, and others have established manufacturing plants in India. This trend is expected to continue as more companies look to set up their manufacturing operations in developing regions.

North America Leading the Charge

In North America, the nebulizer devices market is expanding rapidly, driven by continuous technological innovations. The fast-paced lifestyle in this region demands portable nebulizer devices that can be easily transported and used by patients suffering from asthma and other respiratory diseases such as bronchitis and pneumonia. The adoption of newly launched nebulizers that offer quick drug delivery and high-end technological features with greater accuracy is gaining traction among the U.S. population, thereby boosting the growth of the global nebulizer devices market.

For instance, Omron Healthcare, Inc. introduced the Portable MicroAir Nebulizer device, featuring super small nebulizers with Vibrating Mesh Technology. Weighing only 6 oz, this device fits discreetly in one's palm, making it highly portable. Inspired by such innovations, market companies are developing portable devices for newborns suffering from various respiratory problems such as COPD (Chronic Obstructive Pulmonary Disease) and asthma. These nebulizer devices are equipped with rechargeable batteries, and various types of masks are available for neonatal use.

Asia Pacific Emerging as a Strong Competitor

The Asia Pacific region is witnessing a growing prevalence of chronic obstructive pulmonary disease (COPD), which has intensified the use of nebulizer devices. COPD is a chronic progressive condition that includes lung disorders such as asthma and chronic bronchitis. The increasing exposure to biomass smoke has contributed to the rising COPD cases in this region.

In China, the prevalence rate of COPD is significant, while in India, there are numerous deaths annually due to this condition. The prevalence of COPD in New Zealand and Australia is also noteworthy. The growing disposable income of consumers in the Asia Pacific region enables them to afford advanced technologies and better treatment options. Consequently, the demand for nebulizer devices is expected to intensify in this region in the coming years.

Competitive Analysis

The competitive Analysis of the nebulizer devices market includes several key players:

Agilent Technologies, Inc.
Allied Healthcare Products, Inc.
CareFusion Corporation (subsidiary of Becton, Dickinson and Company)
Covidien plc (subsidiary of Medtronic)
GE Healthcare
GF Health Products Inc.
Omron Healthcare, Inc.
PARI GmbH
Koninklijke Philips N.V.
Others

Market Segmentation

The nebulizer devices market is segmented based on product type, end user, application, and region.

By Product Type:

Compressed Jet Nebulizer
Breath Actuated Pneumatic Nebulizer
Vented Actuated Pneumatic Nebulizer
Ultrasound Nebulizer
Mesh Nebulizer

By End User:

Homecare Settings
Outpatient Settings
Hospitals
Clinics
Long Term Care Centers
Others

By Application:

COPD
Cystic Fibrosis
Asthma
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa

1. Executive Summary

1.1. Global Nebulizer Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Nebulizer Devices Market Outlook, 2019-2031

3.1. Global Nebulizer Devices Market Outlook, by Product Type, Value (US$ Bn), 2019-2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Compressed Jet Nebulizer
    - 3.1.1.1.1. Breath Actuated Pneumatic Nebulizer
    - 3.1.1.1.2. Vented Actuated Pneumatic Nebulizer
  - 3.1.1.2. Ultrasound Nebulizer
  - 3.1.1.3. Mesh Nebulizer
3.2. Global Nebulizer Devices Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 3.2.1. Key Highlights
  - 3.2.1.1. COPD
  - 3.2.1.2. Cystic Fibrosis
  - 3.2.1.3. Asthma
  - 3.2.1.4. Others
3.3. Global Nebulizer Devices Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Homecare Settings
  - 3.3.1.2. Out Patient Settings
  - 3.3.1.3. Others
    - 3.3.1.3.1. Hospitals
    - 3.3.1.3.2. Clinics
    - 3.3.1.3.3. Long Term Centers
3.4. Global Nebulizer Devices Market Outlook, by Region, Value (US$ Bn), 2019-2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Nebulizer Devices Market Outlook, 2019-2031

4.1. North America Nebulizer Devices Market Outlook, by Product Type, Value (US$ Bn), 2019-2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Compressed Jet Nebulizer
    - 4.1.1.1.1. Breath Actuated Pneumatic Nebulizer
    - 4.1.1.1.2. Vented Actuated Pneumatic Nebulizer
  - 4.1.1.2. Ultrasound Nebulizer
  - 4.1.1.3. Mesh Nebulizer
4.2. North America Nebulizer Devices Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 4.2.1. Key Highlights
  - 4.2.1.1. COPD
  - 4.2.1.2. Cystic Fibrosis
  - 4.2.1.3. Asthma
  - 4.2.1.4. Others
4.3. North America Nebulizer Devices Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Homecare Settings
  - 4.3.1.2. Out Patient Settings
  - 4.3.1.3. Others
    - 4.3.1.3.1. Hospitals
    - 4.3.1.3.2. Clinics
    - 4.3.1.3.3. Long Term Centers
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Nebulizer Devices Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 4.4.1.2. U.S. Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 4.4.1.3. U.S. Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 4.4.1.4. Canada Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 4.4.1.5. Canada Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 4.4.1.6. Canada Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Nebulizer Devices Market Outlook, 2019-2031

5.1. Europe Nebulizer Devices Market Outlook, by Product Type, Value (US$ Bn), 2019-2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Compressed Jet Nebulizer
    - 5.1.1.1.1. Breath Actuated Pneumatic Nebulizer
    - 5.1.1.1.2. Vented Actuated Pneumatic Nebulizer
  - 5.1.1.2. Ultrasound Nebulizer
  - 5.1.1.3. Mesh Nebulizer
5.2. Europe Nebulizer Devices Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 5.2.1. Key Highlights
  - 5.2.1.1. COPD
  - 5.2.1.2. Cystic Fibrosis
  - 5.2.1.3. Asthma
  - 5.2.1.4. Others
5.3. Europe Nebulizer Devices Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Homecare Settings
  - 5.3.1.2. Out Patient Settings
  - 5.3.1.3. Others
    - 5.3.1.3.1. Hospitals
    - 5.3.1.3.2. Clinics
    - 5.3.1.3.3. Long Term Centers
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Nebulizer Devices Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.2. Germany Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.3. Germany Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 5.4.1.4. U.K. Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.5. U.K. Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.6. U.K. Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 5.4.1.7. France Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.8. France Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.9. France Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 5.4.1.10. Italy Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.11. Italy Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.12. Italy Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 5.4.1.13. Turkey Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.14. Turkey Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.15. Turkey Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 5.4.1.16. Russia Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.17. Russia Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.18. Russia Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 5.4.1.19. Rest of Europe Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 5.4.1.20. Rest of Europe Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 5.4.1.21. Rest of Europe Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Nebulizer Devices Market Outlook, 2019-2031

6.1. Asia Pacific Nebulizer Devices Market Outlook, by Product Type, Value (US$ Bn), 2019-2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Compressed Jet Nebulizer
    - 6.1.1.1.1. Breath Actuated Pneumatic Nebulizer
    - 6.1.1.1.2. Vented Actuated Pneumatic Nebulizer
  - 6.1.1.2. Ultrasound Nebulizer
  - 6.1.1.3. Mesh Nebulizer
6.2. Asia Pacific Nebulizer Devices Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 6.2.1. Key Highlights
  - 6.2.1.1. COPD
  - 6.2.1.2. Cystic Fibrosis
  - 6.2.1.3. Asthma
  - 6.2.1.4. Others
6.3. Asia Pacific Nebulizer Devices Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Homecare Settings
  - 6.3.1.2. Out Patient Settings
  - 6.3.1.3. Others
    - 6.3.1.3.1. Hospitals
    - 6.3.1.3.2. Clinics
    - 6.3.1.3.3. Long Term Centers
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Nebulizer Devices Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 6.4.1.2. China Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 6.4.1.3. China Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 6.4.1.4. Japan Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 6.4.1.5. Japan Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 6.4.1.6. Japan Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 6.4.1.7. South Korea Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 6.4.1.8. South Korea Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 6.4.1.9. South Korea Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 6.4.1.10. India Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 6.4.1.11. India Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 6.4.1.12. India Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 6.4.1.13. Southeast Asia Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 6.4.1.14. Southeast Asia Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 6.4.1.15. Southeast Asia Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 6.4.1.16. Rest of Asia Pacific Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 6.4.1.17. Rest of Asia Pacific Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 6.4.1.18. Rest of Asia Pacific Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Nebulizer Devices Market Outlook, 2019-2031

7.1. Latin America Nebulizer Devices Market Outlook, by Product Type, Value (US$ Bn), 2019-2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Compressed Jet Nebulizer
    - 7.1.1.1.1. Breath Actuated Pneumatic Nebulizer
    - 7.1.1.1.2. Vented Actuated Pneumatic Nebulizer
  - 7.1.1.2. Ultrasound Nebulizer
  - 7.1.1.3. Mesh Nebulizer
7.2. Latin America Nebulizer Devices Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 7.2.1. Key Highlights
  - 7.2.1.1. COPD
  - 7.2.1.2. Cystic Fibrosis
  - 7.2.1.3. Asthma
  - 7.2.1.4. Others
7.3. Latin America Nebulizer Devices Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Homecare Settings
  - 7.3.1.2. Out Patient Settings
  - 7.3.1.3. Others
    - 7.3.1.3.1. Hospitals
    - 7.3.1.3.2. Clinics
    - 7.3.1.3.3. Long Term Centers
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Nebulizer Devices Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 7.4.1.2. Brazil Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 7.4.1.3. Brazil Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 7.4.1.4. Mexico Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 7.4.1.5. Mexico Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 7.4.1.6. Mexico Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 7.4.1.7. Argentina Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 7.4.1.8. Argentina Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 7.4.1.9. Argentina Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 7.4.1.10. Rest of Latin America Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 7.4.1.11. Rest of Latin America Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 7.4.1.12. Rest of Latin America Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Nebulizer Devices Market Outlook, 2019-2031

8.1. Middle East & Africa Nebulizer Devices Market Outlook, by Product Type, Value (US$ Bn), 2019-2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Compressed Jet Nebulizer
    - 8.1.1.1.1. Breath Actuated Pneumatic Nebulizer
    - 8.1.1.1.2. Vented Actuated Pneumatic Nebulizer
  - 8.1.1.2. Ultrasound Nebulizer
  - 8.1.1.3. Mesh Nebulizer
8.2. Middle East & Africa Nebulizer Devices Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 8.2.1. Key Highlights
  - 8.2.1.1. COPD
  - 8.2.1.2. Cystic Fibrosis
  - 8.2.1.3. Asthma
  - 8.2.1.4. Others
8.3. Middle East & Africa Nebulizer Devices Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Homecare Settings
  - 8.3.1.2. Out Patient Settings
  - 8.3.1.3. Others
    - 8.3.1.3.1. Hospitals
    - 8.3.1.3.2. Clinics
    - 8.3.1.3.3. Long Term Centers
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Nebulizer Devices Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 8.4.1.2. GCC Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 8.4.1.3. GCC Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 8.4.1.4. South Africa Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 8.4.1.5. South Africa Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 8.4.1.6. South Africa Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 8.4.1.7. Egypt Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 8.4.1.8. Egypt Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 8.4.1.9. Egypt Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 8.4.1.10. Nigeria Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 8.4.1.11. Nigeria Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 8.4.1.12. Nigeria Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
  - 8.4.1.13. Rest of Middle East & Africa Nebulizer Devices Market by Product Type, Value (US$ Bn), 2019-2031
  - 8.4.1.14. Rest of Middle East & Africa Nebulizer Devices Market by Application, Value (US$ Bn), 2019-2031
  - 8.4.1.15. Rest of Middle East & Africa Nebulizer Devices Market by End User, Value (US$ Bn), 2019-2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Agilent Technologies, Inc.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Allied Healthcare Products, Inc.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. CareFusion Corporation (sub. Becton, Dickinson and Company)
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Covidien plc (sub. Medtronic)
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. GE Healthcare
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. GF Health Products Inc
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Omron Healthcare, Inc.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. PARI GmbH
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Koninklijke Philips N.V.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations